Back to search
Tumor-Induced Osteomalacia or Epidermal Nevus Syndrome
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Tumor-Induced Osteomalacia or Epidermal Nevus Syndrome trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Tumor-Induced Osteomalacia or Epidermal Nevus Syndrome trials you may qualify forThe primary objectives of this study are to evaluate the effect of burosumab treatment on: * Increasing serum phosphorus levels in adults with TIO or ENS-assoc…
Before switching to the post-marketing study: To evaluate the efficacy and safety of KRN23 after its 144-week once every 4 weeks (Q4W) repeated SC administrati…